Recent research highlights a genetic connection between cancer susceptibility and infertility. A study conducted by Monash University researchers in Melbourne, Australia, has demonstrated that a genetic variant associated with increased cancer risk—including breast and ovarian cancers—also correlates with reduced fertility in mice.
The study focused on the BRCA1 gene, known for its role in cancer protection. By using a specialized mouse model with a targeted BRCA1 gene knockout in eggs, scientists observed significant impacts on reproductive health. Professor Karla Hutt, a senior author and head of the Monash Biomedicine Discovery Institute’s Ovarian Biology Laboratory, emphasized, “The effects of complete BRCA1 loss on egg quantity and fertility were previously unexplored. Our research reveals that BRCA1 is crucial for preserving egg number, quality, and overall fertility throughout the reproductive lifespan.”
Published in eBio Medicine, the study found that mice lacking BRCA1 in their eggs produced smaller litters and experienced a 45 percent reduction in egg maturation rates. Despite these findings, the mice’s reproductive lifespan remained unaffected.
Additionally, preliminary findings in human subjects indicated that anti-Muellerian hormone levels, a common fertility marker, did not align with egg counts in women carrying BRCA mutations. Dr. Amy Winship, a co-first author from Monash University, suggested that women with BRCA mutations should consider family planning strategies such as egg freezing. These individuals, who are at a higher risk for breast and ovarian cancers, may also face fertility challenges due to cancer treatments.
Another recent study, published in the Journal of Clinical Endocrinology and Metabolism, investigated cancer rates among women with primary ovarian insufficiency and their relatives. Analyzing cancer patient records from Utah (1995-2022), researchers found that women with primary ovarian insufficiency had elevated risks for breast and ovarian cancers, while their extended family members faced increased risks for breast, colon, and prostate cancers. Although BRCA mutation data were not included in this study, it is noted that BRCA mutations are linked to a higher risk for these cancers.
These findings underscore the complex interplay between genetic factors influencing both cancer risk and reproductive health, highlighting the need for further research and informed decision-making regarding fertility and cancer risk management.
Related Links:
